Liver disease due to chronic HBV or HCV infection is becoming a leading cause of death
among persons with HIV infection. Both the risk of hepatocellular carcinoma and the risk of …

Chronic hepatitis B (CHB) virus infection is a global public health problem, affecting more
than 400 million people worldwide. The clinical spectrum is wide, ranging from a subclinical …

Tenofovir disoproxil fumarate (TDF) has demonstrated high antiviral efficacy in treatment‐
naive patients with chronic hepatitis B virus (HBV) infection but experience in …

The article presents guidelines from the British HIV Association for the treatment of HIV-1-
infected adults using antiretroviral therapy. It presents data from clinical trials on the …

A key goal of managing HIV in pregnancy and postpartum is to optimise a woman's own
health. Furthermore, one of the major successes in the management of individuals living …

Hepatitis B virus (HBV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and
hepatocellular carcinoma worldwide. Due to the shared modes of transmission, coinfection …

Nearly 10% of the estimated 36 million people having HIV worldwide suffer from chronic
hepatitis B virus (HBV) infection. The advent of new antiviral agents against HBV and the …

One of the major successes in the management of HIV-positive patients has been the
prevention of mother-tochild transmission (MTCT) of HIV-1. With the widespread …

Background Hepatitis B coinfection is common in HIV-positive individuals and as
antiretroviral therapy has made death due to AIDS less common, hepatitis has become …

Coinfection with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) is
associated with considerable liver disease morbidity and mortality. Emerging HIV epidemics …